Difference between revisions of "Hoffmann-La Roche"
Jump to navigation
Jump to search
(Created page with "{{group |wikipedia=https://en.wikipedia.org/wiki/Hoffmann-La_Roche |constitutes=Big pharma |leaders= |logo=Roche.svg |twitter= |start=1896 |founders=Fritz Hoffmann-La Roche |h...") |
(nCoV-2019 antibody test) |
||
| Line 9: | Line 9: | ||
|headquarters= | |headquarters= | ||
}} | }} | ||
| − | {{SMWDocs}} | + | |
| + | ==nCoV-2019 antibody test== | ||
| + | Mai, 2020: The test is the third granted ''emergency approval by the [[FDA]]'' in a urgent procedure and the first commercially available. It gives quick results (18 Min.) and will be accepted worldwide in what has been touted one of Roche's biggest deals. <ref> | ||
| + | https://www.marketwatch.com/story/roche-coronavirus-test-gets-emergency-fda-approval-2020-03-13 | ||
| + | </ref> | ||
| + | The test is not based on the PCR method (which directly detects parts of viral RNA) but addresses antibodies built by the immune system after 1-2 weeks of contact. These may not be specific with a risk for false positives stemming from common cold viruses. The test is self-approved by Roche with the FDA merely giving green light. <ref> | ||
| + | https://www.deutsche-apotheker-zeitung.de/news/artikel/2020/04/14/antikoerpertests-auf-corona-risiko-von-fehlinterpretation | ||
| + | </ref> | ||
| + | |||
| + | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
{{Stub}} | {{Stub}} | ||
Revision as of 12:06, 6 May 2020
 Hoffmann-La Roche  (Big pharma)   | |
|---|---|
 | |
| Formation | 1896 |
| Founder | Fritz Hoffmann-La Roche |
| Member of | Alliance for Biosecurity, European Policy Centre |
| Founder of | Diazepam |
| Subpage | •Hoffmann-La Roche/President |
nCoV-2019 antibody test
Mai, 2020: The test is the third granted emergency approval by the FDA in a urgent procedure and the first commercially available. It gives quick results (18 Min.) and will be accepted worldwide in what has been touted one of Roche's biggest deals. [1] The test is not based on the PCR method (which directly detects parts of viral RNA) but addresses antibodies built by the immune system after 1-2 weeks of contact. These may not be specific with a risk for false positives stemming from common cold viruses. The test is self-approved by Roche with the FDA merely giving green light. [2]
Employee on Wikispooks
| Employee | Job |
|---|---|
| André Hoffmann | Vice-Chairman |
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.
